2015年5月5日 · Raplixa是一种获批用于成年人的生物制品，在标准手术技术如缝合、绷带或烙术无效或无法使用时用来帮助控制小血管的出血。 在应用到出血部位时，Raplixa溶解到血液中，纤维蛋白原与凝血酶蛋白之间就开始出现反应。

Raplixa是一种获批用于成年人的生物制品，在标准手术技术如缝合、绷带或烙术无效或无法使用时用来帮助控制小血管的出血。 在应用到出血部位时，Raplixa溶解到血液中，纤维蛋白原与凝血酶蛋白之间就开始出现反应。 由此形成血凝块，帮助止血。 Raplixa含有纤维蛋白原和凝血酶，这是在人血浆（血液的液体部分）中发现的两种蛋白。 这两种蛋白成分通过一种生产工艺被分别纯化，生产工艺包括病毒失活及移除步骤，可帮助降低血源性传播病毒的风险。 该纤维蛋白胶的 …

FDA 指出，Raplixa是一种生物制剂，批准用于成人标准外科手术中对小血管出血进行控制，在缝合、结扎、烧灼止血无效时可以采用。 Raplixa包括高纯度人类血浆纤维蛋白原和凝血酶派生物，属于混合类干燥型喷雾，小瓶包装。

Raplixa is a fibrin sealant indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as...

Raplixa™ is a novel fibrin sealant containing a blend of human fibrinogen and thrombin in powder form. It is approved in adults to help control bleeding when standard surgical techniques have been insufficient. This article summarizes the product characteristics of …

该药物可能引起严重的过敏反应，包括过敏反应，可能危及生命，需要立即就医。 如果您在服用此药后出现皮疹，瘙痒，荨麻疹，胸痛，头晕或头晕，呼吸困难，吞咽困难或手，脸或嘴有肿胀，请立即告诉医生。

RAPLIXA is a fibrin sealant indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.

FDA 指出，Raplixa是一种生物制剂，批准用于成人标准外科手术中对小血管出血进行控制，在缝合、结扎、烧灼止血无效时可以采用。 Raplixa包括高纯度人类血浆纤维蛋白原和凝血酶派生物，属于混合类干燥型喷雾，小瓶包装。

FDA 指出，Raplixa是一种生物制剂，批准用于成人标准外科手术中对小血管出血进行控制，在缝合、结扎、烧灼止血无效时可以采用。 Raplixa包括高纯度人类血浆纤维蛋白原和凝血酶派生物，属于混合类干燥型喷雾，小瓶包装。

2015年7月4日 · Raplixa™ is a novel fibrin sealant containing a blend of human fibrinogen and thrombin in powder form. It is approved in adults to help control bleeding when standard surgical techniques have...

Supportive treatment where standard surgical techniques are insufficient for improvement of haemostasis. Raplixa must be used in combination with an approved gelatin sponge. Raplixa is indicated in adults over 18 years of age.

2024年3月10日 · Fibrinogen and thrombin human topical powder or patch is used to help control bleeding during surgery when other procedures to close a wound or incision, such as stitches, bands, and heat cannot be used. This medicine is a fibrin sealant.

2015年7月4日 · Raplixa™ is a novel fibrin sealant containing a blend of human fibrinogen and thrombin in powder form. It is approved in adults to help control bleeding when standard surgical techniques have been insufficient. This article summarizes the product characteristics of Raplixa and provides a narrative review of its clinical use and tolerability.

RaplixaTM is a novel fibrin sealant containing a blend of human fibrinogen and thrombin in powder form. It is approved in adults to help control bleeding when stan-dard surgical techniques have been insufficient. This article summarizes the product characteristics of Raplixa and provides a narrative review of its clinical use and tolera-bility.

Raplixa 是一种获批用于成年人的生物制品，在标准手术技术如缝合、绷带 或烙术无效或无法使用时用来帮助控制小血管的出血。 在应用到出血部位时， Raplixa 溶解到血液中，纤维蛋白原与凝血酶蛋白之间就开始出现反应。

2015年4月30日 · Raplixa (fibrin sealant [human]) is a spray-dried fibrin sealant used to help control bleeding during surgery. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. FDA approval history for Raplixa (fibrin sealant [human]) used to treat Hemostasis. Supplied by ProFibrix BV.

2022年4月26日 · RAPLIXA is a fibrin sealant indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.

RAPLIXA prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and RAPLIXAside effects.

2015年7月4日 · Raplixa™ is a novel fibrin sealant containing a blend of human fibrinogen and thrombin in powder form. It is approved in adults to help control bleeding when standard surgical techniques have been insufficient. This article summarizes the product characteristics of Raplixa and provides a narrative review of its clinical use and tolerability.

2022年6月19日 · Raplixa is a medication that's used to help stop mild-to-moderate bleeding in adults during surgery. It's typically used as an alternative option to common surgical methods to stop bleeding, such as suture (the string used to stitch up a wound) or cautery (a practice that burns off tissue to stop bleeding).